Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
British Journal of Cancer
|
June 23, 2022
Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC)
Sukeshi Patel Arora, Laura Tenner, John Sarantopoulos, et al.
Nature Communications
|
March 15, 2017
Suppressive IL-17A<sup>+</sup>Foxp3<sup>+</sup> and ex-Th17 IL-17A<sup>neg</sup>Foxp3<sup>+</sup> T<sub>reg</sub> cells are a source of tumour-associated T<sub>reg</sub> cells
Stephanie Downs-Canner, Sara Berkey, Greg M Delgoffe, et al.
Oncotarget
|
June 28, 2017
Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
Jinyou Liu, Suryavathi Viswanadhapalli, Lauren Garcia, et al.
The Journal of Experimental Medicine
|
April 12, 2006
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
Ilona Kryczek, Linhua Zou, Paulo Rodriguez, et al.
Oncotarget
|
July 10, 2015
p53 and rapamycin are additive
Barbara Christy, Marco Demaria, Judith Campisi, et al.
Cancer Research
|
October 12, 2022
PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer
Juyeong Hong, Ji Hoon Lee, Zhao Zhang, et al.
Journal for Immunotherapy of Cancer
|
February 9, 2023
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects
Haiyan Bai, Alvaro S Padron, Yilun Deng, et al.
Journal for Immunotherapy of Cancer
|
June 9, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Mary L Disis, Sarah F Adams, Jyoti Bajpai, et al.
NPJ Precision Oncology
|
May 24, 2024
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis
Behnam Ebrahimi, Suryavathi Viswanadhapalli, Uday P Pratap, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
British Journal of Cancer
|
June 23, 2022
Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC)
Sukeshi Patel Arora, Laura Tenner, John Sarantopoulos, et al.
Nature Communications
|
March 15, 2017
Suppressive IL-17A<sup>+</sup>Foxp3<sup>+</sup> and ex-Th17 IL-17A<sup>neg</sup>Foxp3<sup>+</sup> T<sub>reg</sub> cells are a source of tumour-associated T<sub>reg</sub> cells
Stephanie Downs-Canner, Sara Berkey, Greg M Delgoffe, et al.
Oncotarget
|
June 28, 2017
Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
Jinyou Liu, Suryavathi Viswanadhapalli, Lauren Garcia, et al.
The Journal of Experimental Medicine
|
April 12, 2006
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
Ilona Kryczek, Linhua Zou, Paulo Rodriguez, et al.
Oncotarget
|
July 10, 2015
p53 and rapamycin are additive
Barbara Christy, Marco Demaria, Judith Campisi, et al.
Cancer Research
|
October 12, 2022
PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer
Juyeong Hong, Ji Hoon Lee, Zhao Zhang, et al.
Journal for Immunotherapy of Cancer
|
February 9, 2023
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects
Haiyan Bai, Alvaro S Padron, Yilun Deng, et al.
Journal for Immunotherapy of Cancer
|
June 9, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Mary L Disis, Sarah F Adams, Jyoti Bajpai, et al.
NPJ Precision Oncology
|
May 24, 2024
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis
Behnam Ebrahimi, Suryavathi Viswanadhapalli, Uday P Pratap, et al.
Page
of 2